A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder

Medicine & Life Sciences

• Vortioxetine 100%
• Major Depressive Disorder 61%
• Placebos 40%
• Safety 34%
• Depression 10%
• Suicide 9%
• serotonin 5 receptor 7%
• Flatulence 7%
• Serotonin Plasma Membrane Transport Proteins 6%
• Suicidal Ideation 6%
• Serotonin Receptors 6%
• Vital Signs 5%
• Dizziness 5%
• Constipation 5%
• Diagnostic and Statistical Manual of Mental Disorders 5%
• Nausea 4%
• Vomiting 4%
• Mouth 4%
• Headache 4%
• Diarrhea 4%
• Psychological Inhibition 4%
• Electrocardiography 4%
• Therapeutics 1%